The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
ROS‐Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy
Open accessAbstract
The application of nanoparticles (NPs) to drug delivery has led to the development of novel nanotherapeutics for the treatment of various diseases including cancer. However, clinical use of NP‐mediated drug delivery has not always translated into improved survival of cancer patients, in part due to the suboptimal properties of NP platforms, such as premature drug leakage during preparation, storage, or blood circulation, lack of active targeting to tumor tissue and cells, and poor tissue penetration. Herein, an innovative reactive oxygen species (ROS)‐responsive polyprodrug is reported that can self‐assemble into stable NPs with high drug loading. This new NP platform is composed of the following key components: (i) polyprodrug inner core that can respond to ROS for triggered release of intact therapeutic molecules, (ii) polyethylene glycol (PEG) outer shell to prolong blood circulation; and (iii) surface‐encoded internalizing RGD (iRGD) to enhance tumor targeting and tissue penetration. These targeted ROS‐responsive polyprodrug NPs show significant inhibition of tumor cell growth both in vitro and in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Self-citationTargeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Schafer, F. Q., & Buettner, G. R. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00480-4 · Cited by 4,587
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
Self-citationReactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
Zhou, Z., Song, J., Nie, L., & Chen, X. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00271d · Cited by 2,098
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
Chemistry and biology of reactive oxygen species in signaling or stress responses
Dickinson, B. C., & Chang, C. J. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.607 · Cited by 1,821
Cheng, R., Feng, F., Meng, F., Deng, C., Feijen, J., & Zhong, Z. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.030 · Cited by 1,360
Nanomedicine—Challenge and Perspectives
Riehemann, K., Schneider, S. W., Luger, T. A., Godin, B., Ferrari, M., & Fuchs, H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802585 · Cited by 1,305
Du, J.-Z., Du, X.-J., Mao, C.-Q., & Wang, J. (2011) · Journal of the American Chemical Society · doi:10.1021/ja207150n · Cited by 1,172
Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Girard, O. M., Hanahan, D., Mattrey, R. F., & Ruoslahti, E. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.013 · Cited by 1,136
Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs
Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Greenwald, D. R., & Ruoslahti, E. (2010) · Science · doi:10.1126/science.1183057 · Cited by 1,075
Self-Assembled Lipid−Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform
Zhang, L., Chan, J. M., Gu, F. X., Rhee, J.-W., Wang, A. Z., Radovic-Moreno, A. F., Alexis, F., Langer, R., & Farokhzad, O. C. (2008) · ACS Nano · doi:10.1021/nn800275r · Cited by 1,038
Self-citationTargeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy
Yu, M. K., Park, J., & Jon, S. (2012) · Theranostics · doi:10.7150/thno.3463 · Cited by 883
Wang, Y., Zhou, K., Huang, G., Hensley, C., Huang, X., Ma, X., Zhao, T., Sumer, B. D., DeBerardinis, R. J., & Gao, J. (2014) · Nature Materials · doi:10.1038/nmat3819 · Cited by 773
Wilson, D. S., Dalmasso, G., Wang, L., Sitaraman, S. V., Merlin, D., & Murthy, N. (2010) · Nature Materials · doi:10.1038/nmat2859 · Cited by 747
Reactive‐Oxygen‐Species‐Responsive Drug Delivery Systems: Promises and Challenges
Saravanakumar, G., Kim, J., & Kim, W. J. (2017) · Advanced Science · doi:10.1002/advs.201600124 · Cited by 675
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy
Maeda, H. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00134-4 · Cited by 662
Hu, X., Hu, J., Tian, J., Ge, Z., Zhang, G., Luo, K., & Liu, S. (2013) · Journal of the American Chemical Society · doi:10.1021/ja409686x · Cited by 605
Andrew MacKay, J., Chen, M., McDaniel, J. R., Liu, W., Simnick, A. J., & Chilkoti, A. (2009) · Nature Materials · doi:10.1038/nmat2569 · Cited by 580
Kolishetti, N., Dhar, S., Valencia, P. M., Lin, L. Q., Karnik, R., Lippard, S. J., Langer, R., & Farokhzad, O. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011368107 · Cited by 565
Self-citationSelf-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation
Shi, J., Xiao, Z., Kamaly, N., & Farokhzad, O. C. (2011) · Accounts of Chemical Research · doi:10.1021/ar200054n · Cited by 476
Self-citationLight‐Activated Hypoxia‐Responsive Nanocarriers for Enhanced Anticancer Therapy
Qian, C., Yu, J., Chen, Y., Hu, Q., Xiao, X., Sun, W., Wang, C., Feng, P., Shen, Q., & Gu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201505869 · Cited by 466
Polymer-drug conjugates: Recent development in clinical oncology
Li, C., & Wallace, S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.009 · Cited by 436
Shim, M. S., & Xia, Y. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201209633 · Cited by 402
Prodrugs for improving tumor targetability and efficiency
Mahato, R., Tai, W., & Cheng, K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.02.002 · Cited by 353
Hu, X., Liu, G., Li, Y., Wang, X., & Liu, S. (2015) · Journal of the American Chemical Society · doi:10.1021/ja5105848 · Cited by 325
Self-citationYuan, Y., Liu, J., & Liu, B. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201402189 · Cited by 302
ROS‐responsive drug delivery systems
Liang, J., & Liu, B. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10014 · Cited by 274
Sun, W., Li, S., Häupler, B., Liu, J., Jin, S., Steffen, W., Schubert, U. S., Butt, H., Liang, X., & Wu, S. (2017) · Advanced Materials · doi:10.1002/adma.201603702 · Cited by 251
Xu, X., Wu, J., Liu, Y., Yu, M., Zhao, L., Zhu, X., Bhasin, S., Li, Q., Ha, E., Shi, J., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201601273 · Cited by 250
Self-citationWang, M., Sun, S., Neufeld, C. I., Perez‐Ramirez, B., & Xu, Q. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201407234 · Cited by 249
Duncan, R., & Vicent, M. J. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.12.005 · Cited by 230
Zhai, S., Hu, X., Hu, Y., Wu, B., & Xing, D. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.01.002 · Cited by 228
Curcumin polymers as anticancer conjugates
Tang, H., Murphy, C. J., Zhang, B., Shen, Y., Van Kirk, E. A., Murdoch, W. J., & Radosz, M. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.06.007 · Cited by 204
Zhu, X., Xu, Y., Solis, L. M., Tao, W., Wang, L., Behrens, C., Xu, X., Zhao, L., Liu, D., Wu, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505629112 · Cited by 203
Self-citationMiller, K., Erez, R., Segal, E., Shabat, D., & Satchi‐Fainaro, R. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200805133 · Cited by 179
Li, J., Ke, W., Wang, L., Huang, M., Yin, W., Zhang, P., Chen, Q., & Ge, Z. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.029 · Cited by 144
Chain‐Shattering Polymeric Therapeutics with On‐Demand Drug‐Release Capability
Zhang, Y., Yin, Q., Yin, L., Ma, L., Tang, L., & Cheng, J. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201300497 · Cited by 141
Ultra-small lipid–polymer hybrid nanoparticles for tumor-penetrating drug delivery
Dehaini, D., Fang, R. H., Luk, B. T., Pang, Z., Hu, C. J., Kroll, A. V., Yu, C. L., Gao, W., & Zhang, L. (2016) · Nanoscale · doi:10.1039/c6nr04091h · Cited by 109
Design strategies to improve soluble macromolecular delivery constructs
Christie, R. J., & Grainger, D. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00229-6 · Cited by 103
Homsi, J., Simon, G. R., Garrett, C. R., Springett, G. M., Conti, R. C. D., Chiappori, A., Münster, P. N., Burton, M. K., Stromatt, S. C., Allievi, C., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2821 · Cited by 103
Smart and hyper-fast responsive polyprodrug nanoplatform for targeted cancer therapy
Xu, X., Cheng, Y.-J., Wu, J., Cheng, H. B., Cheng, S., Zhuo, R., & Zhang, X. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.056 · Cited by 95
Self-citationcRGD-functionalized mPEG-PLGA-PLL nanoparticles for imaging and therapy of breast cancer
Liu, P., Qin, L., Wang, Q., Sun, Y., Zhu, M., Shen, M., & Duan, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.008 · Cited by 94
Yang, J. J., Liu, W., Sui, M., Tang, J., & Shen, Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.022 · Cited by 93
Sutherland, M., Gordon, A. H., Shnyder, S. D., Patterson, L. H., & Sheldrake, H. M. (2012) · Cancers · doi:10.3390/cancers4041106 · Cited by 64
Cited by
Reactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,443
Self-citationMa, B., Wang, S., Liu, F., Zhang, S., Duan, J., Li, Z., Kong, Y., Sang, Y., Liu, H., Bu, W., et al. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b08714 · Cited by 1,222
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Nanomedicine in cancer therapy
Fan, D., Cao, Y., Cao, M., Wang, Y., Cao, Y., & Gong, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01536-y · Cited by 878
Xuan, L., Ju, Z., Skonieczna, M., Zhou, P., & Huang, R. (2023) · MedComm · doi:10.1002/mco2.327 · Cited by 807
Metadata
- Authors
- Xu, X., Saw, P. E., Tao, W., Li, Y., Ji, X., Bhasin, S., Liu, Y., Ayyash, D., Rasmussen, J., Huo, M., Shi, J., & Farokhzad, O. C.
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2017-07-06
- Volume
- 29
- Issue
- 33
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W2727426256
- Cited by
- 499
- References
- 49
- FWCI
- 17.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.